XIST A-Repeat Minigene for Localized Gene Repression
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current technologies lack the ability to modulate gene expression specifically within a small chromosomal region without affecting genes across the whole chromosome, which is essential for addressing chromosomal abnormalities and pathogenic copy number variations.
Innovation Solution
The use of XIST A-repeat minigenes, which are targeted to specific chromosomal regions, allows for the repression of gene expression in a localized manner by inserting a silencing sequence comprising a promoter and an XIST A-repeat domain into the genome at a specific site, up to 5 Mb away from the target gene promoter.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Quantity of substance
If full-length XIST RNA is used to silence genes, then chromosome-wide gene silencing is achieved, but the ability to limit silencing to a small chromosomal region is lost
Solution Approach 1:
The patent segments the full-length XIST RNA (14-19 kb) into a minimal functional A-repeat domain (450 bp) that retains silencing capability but limits spread to a localized chromosomal region. This segmentation enables targeted delivery while maintaining gene silencing function, resolving the contradiction between comprehensive silencing coverage and feasible targeted delivery.
2Reliability
If full-length XIST cDNA is used, then comprehensive chromosome silencing is achieved, but technical obstacles to manipulation and in vivo delivery occur
Solution Approach 1:
The patent extracts only the essential A-repeat domain (450 bp) from the full-length XIST cDNA (14-19 kb), removing non-essential sequences that contribute to chromosome-wide spread. This extraction maintains reliable gene silencing efficacy while dramatically reducing transgene size to overcome in vivo delivery obstacles.
Solution Approach 2:
The A-repeat minigene provides localized silencing quality by restricting the silencing effect to a specific chromosomal region (up to 5 Mb from insertion site) rather than the entire chromosome. This local quality approach maintains silencing reliability in the target region while avoiding the complexity of delivering and controlling full-length XIST.
3Adaptability or versatility
If gene repression is targeted to a small chromosomal region, then localized gene expression modulation is achieved, but the ability to silence genes throughout the whole chromosome is lost
Solution Approach 1:
The patent creates a dynamic silencing system where the A-repeat minigene can be targeted to different chromosomal locations via customizable guide sequences, enabling adaptable targeted repression. The silencing scope is dynamically controlled by the insertion site, affecting genes within up to 5 Mb of the target, providing versatility for different therapeutic applications.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach effectively silences genes within a limited chromosomal region, up to 10 Mb centered on the insertion site, without causing chromosome-wide gene silencing, thus providing a localized and specific method for modulating gene expression.
Implementation Method 1
The RNA transcribed from the fusion nucleotide sequence is sufficient to mediate silencing of neighboring genes whose promoters are located 20 kb-5 mb from the target site
Data Source
AI summary
This invention relates to compositions and methods for modulating gene expression, e.g., allele-specific gene expression, and to DNA sequences that can be integrated into targeted genomic locations (e.g., introns, exons, non-coding regions) within or near one or more alleles and confer reduced expression of said allele(s). Targeted alleles include, but are not limited to, gene sequences, translocated sequences, fully or partially duplicated sequences, and integrated viral-derived sequences.